Clinical and anamnestic features of patients with diseases of the cervix and incompetence of the pelvic floor muscles

• Gulirano A. Karimova
• Olga K. Doronina
• Mekan R. Orazov
• Liliya R. Toktar
• Marina G. Lebedeva

Abstract

Background. Cervical diseases and pelvic floor muscle failure are common among women of reproductive age. The occurrence cervical disease of and POP has a negative impact on the incidence of women.

Aim. To study anamnestic factors and clinical manifestations of cervical diseases in patients with and without pelvic floor dysfunction.

Material and methods. First (the main) group (n=66), included patients with histologically confirmed diseases of the cervix: leukoplakia (n=38), various cervical dysplasia (n=22), cervical ectopy (n=6) and POP. The second group included women (n=25) with diseases of the cervix: leukoplakia (n=9), various cervical dysplasia (n=13), cervical ectopy (n=2) and chronic cervicitis (n=1), but without POP.

Results. According to the results of study, it was found that the group of patients with cervical diseases and POP, compared with the group of patients with cervical diseases, but without POP, have higher average age, body mass index, frequency of pregnancy and childbirth, somatic and gynecological diseases per 100 studied.

Conclusion. Late reproductive age, high body mass index, a large number of pregnancies and childbirth in anamnesis can be considered unfavorable factors in relation to POP in patients with cervical diseases. They are also characterized by a high frequency of concomitant somatic and gynecological diseases. Patients with POP are more likely to become infected with HPV than patients without POP.

Keywords:pelvic floor muscle insufficiency; pelvic organ prolapse; cervical disease; HPV

REFERENCES

1. Fang G., Hong L., Liu C., Yang Q., Zhang Q., Li Y., et al. Oxidative status of cardinal ligament in pelvic organ prolapse. Exp Ther Med. 2018; 16 (4): 3293–302. DOI: https://doi.org/10.3892/etm.2018.6633

2. Geoffrion R., Louie K., Hyakutake M.T., et al. Study of prolapse-induced cervical elongation. J Obstet Gynaecol Can. 2016; 38 (3): 265–9. DOI: https://doi.org/10.1016/j.jogc.2016.01.008

3. Aliev E.А., Akhmedova E.V. Pelvic organ prolapse. Koloproktologiya [Coloproctology]. 2016; 2 (56): 42–7. (in Russian)

4. Dheresa M., Assefa N., Berhane Y., Worku A., Mingiste B., et al. Gynecological morbidity among women in reproductive age: a systematic review and meta-analysis. J Womens Health Care. 2017; 6: 367. DOI: https://doi.org/10.4172/2167-0420.1000367

5. Blesmanovich А.Е., Petrov Yu.А., Bagnovskaya А.G. From background processes to cervical cancer: causes, diagnosis and prevention. Glavniy vrach Yuga Rossii [Chief Physician of the South of Russia]. 2020; 4 (74): 36–9. (in Russian)

6. Gvozdev М.Y., Tupikina N.V., Kasyan G.R., Pushkar’ D.Y. Pelvic organ prolapse in the clinical practice of a urologist: Methodological guidelines No. 3. Moscow: ABVpress, 2016: 48 p. (in Russian)

7. Gladkaya V.S., Gritsinskaya V.L., Medvedeva N.N. Current trends in reproductive health and reproductive behavior of the female population in Russia. Mat’ i ditya v Kuzbasse [Mother and Child in Kuzbass]. 2017; (1): 10–5. (in Russian)

8. Gribova S.N., Khripunova G.I. Modern ideas about the etiology, pathogenesis,methods of diagnosis and treatment of background and precancerous diseases of the cervix. Saratovskiy nauchno-meditsinskiy zhurnal [Saratov Journal of Medical Scientific Research]. 2008; 2 (20): 18–23. (in Russian)

9. Kaprin А.D., Novikova E.G., Trushina O.I., Gretsova O.P. Cervical cancer screening - unsolved problems. Issledovaniya i praktika v medicine [Research and Practice in Medicine]. 2015; 2 (1): 36-41. (in Russian)

10. Levshin V.F., Zavel’skaya А.У Risk factors and prevention of cervical cancer. Voprosy oncologii [Problems in Oncology]. 2017; 3 (63): 506-6. (in Russian)

11. Sherrard J., Wilson J., Donders G., Mendling W., Jensen J.S. 2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. Int J STD AIDS. 2018; 29 (13): 1258-72.

12. WHO Guidelines for the Use of Thermal Ablation for Cervical Pre-Cancer Lesions. Geneva: World Health Organization, 2019.

13. Kamoeva S.V. Pathogenetic aspects of prognosis, diagnosis and treatment of pelvic organs: Diss. Moscow, 2015. (in Russian)

14. Weintraub A.Y., Glinter H., Marcus-Braun N. Narrative review of the epidemiology, diagnosis and pathophysiology of pelvic organ prolapse. Int Braz J Urol. 2020; 46 (1): 5-14. DOI: https://doi.org/10.1590/S1677-5538.IBJU.2018.0581

15. Hallock J.L., Handa V.L. The epidemiology of pelvic floor disorders and childbirth: an update. Obstet Gynecol Clin North Am. 2016; 43 (1): 1-13. DOI: https://doi.org/10.1016/j.ogc.2015.10.008

16. Blomquist J.L., Carroll M., Munoz A., Handa V.L. Pelvic floor muscle strength and the incidence of pelvic floor disorders after vaginal and cesarean delivery. Am J Obstet Gynecol. 2020; 222 (1): 62.e1-8. DOI: https://doi.org/10.1016/j.ajog.2019.08.003 Epub 2019 Aug 8. PMID: 31422064.

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)